Teradata highlighted three AI-powered projects in healthcare and life sciences that enhance disease prediction, patient engagement, and regulatory compliance. A European research institution developed a model predicting disease onset up to 10 years ahead, aiding healthcare planning. A U.S. health system improved patient engagement by 520% using AI-driven digital care programs for rural populations. Additionally, a major U.S. healthcare payer used AI for secure, scalable regulatory compliance. These cases demonstrate how AI can deliver real-world healthcare benefits while maintaining data governance and security. Teradata aims to help healthcare organizations turn data into actionable intelligence efficiently and securely.
Teradata's new AI customer engagements in healthcare and life sciences provide context for this sector's market activity. For readers following healthcare stocks, here is Pluang's market snapshot as of Oct 07, 2026 19:12 WIB: of 100 priced US health-sector stocks, 44 rose and 50 fell. Notable movers include ABEO at USD 5.11 with a 2.00% gain and 97% buy orders, SMMT at USD 16.97 down 1.96% with 83% sell orders, and DNA at USD 12.17 down 1.93% with 58% buy orders.
BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...
Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...
Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
